Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Association of the STAT4 Gene rs7574865 Polymorphism with IFN-γ Levels in Patients with Systemic Lupus Erythematosus.
Esparza Guerrero Y, Vazquez Villegas ML, Nava Valdivia CA, Ponce Guarneros JM, Perez Guerrero EE, Gomez Ramirez EE, Ramirez Villafaña M, Contreras Haro B, Martinez Hernandez A, Cardona Muñoz EG, Nuño Arana I, Gallardo Moya SG, Celis A, Gonzalez Lopez L, Gamez Nava JI, Saldaña Cruz AM. Esparza Guerrero Y, et al. Among authors: nava valdivia ca. Genes (Basel). 2023 Feb 21;14(3):537. doi: 10.3390/genes14030537. Genes (Basel). 2023. PMID: 36980810 Free PMC article.
Functional disability is related to serum chemerin levels in rheumatoid arthritis.
Vazquez-Villegas ML, Gamez-Nava JI, Saldaña-Cruz AM, Celis A, Sanchez-Rodriguez EN, Perez-Guerrero EE, Ramirez-Villafaña M, Nava-Valdivia CA, Contreras-Haro B, Vasquez-Jimenez JC, Ponce-Guarneros JM, Barocio-Ramirez AK, Cerpa-Cruz S, Alcaraz-Lopez MF, Gonzalez-Lopez L. Vazquez-Villegas ML, et al. Among authors: nava valdivia ca. Sci Rep. 2021 Apr 16;11(1):8360. doi: 10.1038/s41598-021-87235-6. Sci Rep. 2021. PMID: 33863926 Free PMC article.
Steroid Resistance Associated with High MIF and P-gp Serum Levels in SLE Patients.
Beltrán-Ramírez A, Muñoz-Valle JF, Gamez-Nava JI, Saldaña-Cruz AM, Gonzalez-Lopez L, Padilla-Ortega A, Arias-García FI, Sánchez-Zuno GA, Nava-Valdivia CA, Ponce-Guarneros JM, García-Galindo JJ, Perez-Guerrero EE. Beltrán-Ramírez A, et al. Among authors: nava valdivia ca. Molecules. 2022 Oct 10;27(19):6741. doi: 10.3390/molecules27196741. Molecules. 2022. PMID: 36235275 Free PMC article.
Myostatin Levels and the Risk of Myopenia and Rheumatoid Cachexia in Women with Rheumatoid Arthritis.
Gonzalez-Ponce F, Gamez-Nava JI, Gomez-Ramirez EE, Ramirez-Villafaña M, Jacobo-Cuevas H, Rodriguez-Jimenez NA, Olivas-Flores EM, Esparza-Guerrero Y, Martelli-García A, Santiago-Garcia AP, Nava-Valdivia CA, Martinez-Hernandez A, Gonzalez-Vazquez SA, Celis A, Cabrera-Pivaral CE, Totsuka-Sutto S, Cardona-Muñoz EG, Gonzalez-Lopez L. Gonzalez-Ponce F, et al. Among authors: nava valdivia ca. J Immunol Res. 2022 May 10;2022:7258152. doi: 10.1155/2022/7258152. eCollection 2022. J Immunol Res. 2022. PMID: 35592686 Free PMC article.
Genetic Variant HLA-DRB1*0403 and Therapeutic Response to Disease-Modifying Therapies in Multiple Sclerosis: A Case-Control Study.
Gomez-Gaitan EA, Garcia-Ortega YE, Saldaña-Cruz AM, Contreras-Haro B, Gamez-Nava JI, Perez-Guerrero EE, Nava-Valdivia CA, Gallardo-Moya S, Martinez-Hernandez A, Gonzalez Lopez L, Rios-Gonzalez BE, Marquez-Pedroza J, Mendez-Del Villar M, Esparza-Guerrero Y, Villagomez-Vega A, Macias Islas MA. Gomez-Gaitan EA, et al. Among authors: nava valdivia ca. Int J Mol Sci. 2023 Sep 27;24(19):14594. doi: 10.3390/ijms241914594. Int J Mol Sci. 2023. PMID: 37834042 Free PMC article.
Complementary Therapies and Their Association with Problems in Therapeutic Adherence to Conventional Synthetic DMARDs in Rheumatoid Arthritis: A Cross-Sectional Study.
Santiago-Garcia AP, Gamez-Nava JI, Avalos-Salgado FA, Cerpa-Cruz S, Amaya-Cabrera EL, Gutierrez-Ureña S, Nava-Valdivia CA, Gonzalez-Vazquez S, Arevalo-Simental DE, Gomez-Camarena JJ, Ponce-Guarneros JM, Rodriguez-Jimenez NA, Saldaña-Cruz AM, Cardona-Muñoz EG, Gonzalez-Lopez L; Research Group for Factors Related to Therapeutic Outcomes in Autoimmune Diseases. Santiago-Garcia AP, et al. Among authors: nava valdivia ca. Healthcare (Basel). 2023 Dec 25;12(1):49. doi: 10.3390/healthcare12010049. Healthcare (Basel). 2023. PMID: 38200955 Free PMC article.
Risk Factors Associated with Adverse Events Leading to Methotrexate Withdrawal in Elderly Rheumatoid Arthritis Patients: A Retrospective Cohort Study.
Avalos-Salgado FA, Gonzalez-Lopez L, Gonzalez-Vazquez S, Ponce-Guarneros JM, Santiago-Garcia AP, Amaya-Cabrera EL, Arellano-Cervantes R, Gutiérrez-Aceves JA, Alcaraz-Lopez MF, Nava-Valdivia CA, Gonzalez-Ponce F, Rodriguez-Jimenez NA, Macias-Islas MA, Valdivia-Tangarife ER, Saldaña-Cruz AM, Cardona-Muñoz EG, Gamez-Nava JI; Research Group for Factors Related to Therapeutic Outcomes in Autoimmune Diseases. Avalos-Salgado FA, et al. Among authors: nava valdivia ca. J Clin Med. 2024 Mar 24;13(7):1863. doi: 10.3390/jcm13071863. J Clin Med. 2024. PMID: 38610627 Free PMC article.
Assessment of serum macrophage migration inhibitory factor (MIF), adiponectin, and other adipokines as potential markers of proteinuria and renal dysfunction in lupus nephritis: a cross-sectional study.
Gamez-Nava JI, Diaz-Rizo V, Perez-Guerrero EE, Muñoz-Valle JF, Saldaña-Cruz AM, Fajardo-Robledo NS, Jacobo-Cuevas H, Nava-Valdivia CA, Alcaraz-Lopez MF, Trujillo X, Huerta M, Cardona-Muñoz EG, Gonzalez-Lopez L. Gamez-Nava JI, et al. Among authors: nava valdivia ca. Biomark Res. 2020 Oct 28;8:55. doi: 10.1186/s40364-020-00236-x. eCollection 2020. Biomark Res. 2020. PMID: 33133605 Free PMC article.